Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Dapagliflozin 5mg Tablets
Therapeutic Category
Antidiabetic, Cardiology, Diabetic
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dapoflit 5 Tablet contains Dapagliflozin, a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus and certain cardiovascular and renal conditions. It works by blocking SGLT2 in the proximal renal tubules, reducing glucose reabsorption and increasing urinary glucose excretion, thereby lowering blood sugar levels independently of insulin. Beyond glycemic control, dapagliflozin has demonstrated cardiovascular and renal protective effects, reducing hospitalization for heart failure and slowing progression of chronic kidney disease. The 5 mg dose is often used as a starting dose or in patients requiring lower exposure due to comorbidities or concomitant therapy.
Common side effects include urinary tract infections, genital mycotic infections, increased urination, and mild dehydration. Some patients may experience dizziness, thirst, or low blood pressure, especially in combination with diuretics. Rare but serious adverse effects include diabetic ketoacidosis (even with normal blood sugar levels), Fournier’s gangrene, and acute kidney injury. Hypoglycemia risk increases when used with insulin or sulfonylureas.
Dapoflit 5 Tablet is indicated for the management of type 2 diabetes mellitus as monotherapy or in combination with other antidiabetic agents when diet and exercise alone are insufficient. It is also used in adults with heart failure with reduced ejection fraction (HFrEF) and as part of therapy in chronic kidney disease (CKD) to reduce the risk of progression and hospitalization, as advised by a physician.
Dapoflit 5 Tablet should be taken once daily at the same time each day, with or without food, as prescribed. It is not recommended in type 1 diabetes or for the treatment of diabetic ketoacidosis. Caution is advised in patients with hypotension, dehydration, recurrent UTIs, or impaired renal function. Adequate hydration is essential to avoid volume depletion. Pregnant and breastfeeding women should use this medication only if the potential benefit justifies the risk. Regular monitoring of kidney function, blood sugar levels, and signs of infection is important during therapy. Patients should be educated on recognizing symptoms of ketoacidosis such as nausea, vomiting, abdominal pain, and fatigue, and seek immediate medical attention if they occur.
Store Dapoflit 5 Tablet in a cool, dry place below 30°C, away from moisture and direct sunlight. Keep in the original blister pack and out of reach of children. Do not use beyond the expiry date printed on the strip.
Composition : Dapagliflozin (10mg) + Metformin (500mg) ER + Sitagliptin (100mg) Tablet
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Dapagliflozin 10mg Tablets
Composition : Dapagliflozin 5mg Tablets
Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets
Composition : Sitagliptin Phosphate I.P. 100mg + Dapagliflozin Propanediol U.S.P. 10mg Tablets
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Dapagliflozin 5mg Tablets have strong demand in the antidiabetic segment, making them a high-potential product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes management, especially for patients requiring low-dose SGLT2 inhibitor therapy or dose-adjustment cases. It strengthens their diabetes care portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Dapagliflozin 5mg Tablets with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady chronic prescription demand, repeat sales, and long-term growth in the diabetes care market when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this antidiabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.